4 European Projects Found
Searched on 125080 European Projects
FINISHED
European clinical study for the application of regenerative heart valves (ESPOIR)
Start date: Jan 1, 2012, End date: Dec 31, 2016,
Acquired and congenital heart disease can necessitate heart valve replacement. However, current heart valve substitutes are not considered ideal as they need anticoagulation, bearing the risk of bleeding when manufactured from non-organic material, or they degenerate when they derive from animals or human tissue donators (homografts) thereby leading to frequent reoperation especially in the young ...
Read Project
15
Partners Participants
FINISHED
European Paediatric Oncology Off-Patent Medicines Consortium (EPOC)
Start date: Feb 1, 2009, End date: Oct 31, 2013,
Cancer chemotherapy has a key role in the successful treatment of a number of childhood cancers. Nevertheless, at least 20% of patients are not cured by current therapies and a significant number experience debilitating toxicities. Given the high cure rates and potential life-span of survivors of childhood cancer, it is particularly important to minimize the impact of potential chronic toxicities. ...
Read Project
11
Partners Participants
FINISHED
Safety Of non-Steroidal anti-inflammatory drugs (SOS)
Start date: Nov 1, 2008, End date: Apr 30, 2012,
"The Safety Of non-Steroidal anti-inflammatory drugs (SOS) proposal aims to assess the relative cardiovascular (CVD) and gastrointestinal (GI) safety of non-steroidal anti-inflammatory drugs (NSAIDs). The NSAIDs are divided in traditional NSAIDs (tNSAIDs) and the newer COX-II inhibitors(coxibs). The aim will be fulfilled by a two-phase approach comprising systematic reviews and synthesis of CVD an ...
Read Project
11
Partners Participants
FINISHED
Relating Expectations and needs to Participation and Empowerment of children in Clinical Trials (RESPECT)
Start date: Jun 1, 2008, End date: Aug 31, 2011,
"There are two objectives for this project, firstly to clarify the expectations and needs of children and their families who have participated or who might participate in clinical trials for new drugs in Europe. Secondly, to identify methods by which the expectations and needs can be translated into empowering and motivating participants in future clinical trails research. This will be achieved in ...
Read Project
